Showing 1 - 5 results of 5 for search 'Holger Sültmann', query time: 0.01s Refine Results
  1. 1
    Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis

    Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis by Ann-Kathrin Daum, Lisa Schlicker, Marc A. Schneider, Thomas Muley, Ursula Klingmüller, Almut Schulze, Michael Thomas, Petros Christopoulos, Holger Sültmann

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer

    Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer by Samaneh Eickelschulte, Samaneh Eickelschulte, Samaneh Eickelschulte, Adam Kaczorowski, Florian Janke, Anja Lisa Riediger, Anja Lisa Riediger, Anja Lisa Riediger, Anja Lisa Riediger, Olga Lazareva, Olga Lazareva, Sarah Böning, Glen Kristiansen, Constantin Schwab, Constantin Schwab, Albrecht Stenzinger, Holger Sültmann, Holger Sültmann, Stefan Duensing, Anette Duensing, Magdalena Görtz, Magdalena Görtz

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.

    Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y. by Petra Massoner, Karl G Kugler, Karin Unterberger, Ruprecht Kuner, Laurin A J Mueller, Maria Fälth, Georg Schäfer, Christof Seifarth, Simone Ecker, Irmgard Verdorfer, Armin Graber, Holger Sültmann, Helmut Klocker

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer

    Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer by Florian Janke, Mateo Gasser, Arlou K. Angeles, Anja L. Riediger, Magdalena Görtz, Louise Appenheimer, Astrid K. Laut, Simon Ogrodnik, Sabrina Gerhardt, Albrecht Stenzinger, Marc A. Schneider, Michael Thomas, Petros Christopoulos, Holger Sültmann

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study

    Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study by Daniel Schmitz, Stefan Prax, Martin Kliment, Felix Gocke, Daniel Kazdal, Michael Allgäuer, Roland Penzel, Martina Kirchner, Olaf Neumann, Holger Sültmann, Jan Budczies, Peter Schirmacher, Frank Bergmann, Jörg-Peter Ritz, Raoul Hinze, Felix Grassmann, Jochen Rudi, Albrecht Stenzinger, Anna-Lena Volckmar

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: